These are this Thursday’s top ten analyst upgrades, downgrades, and initiations seen from Wall Street research calls:
American Tower Corp. (NYSE: AMT) Started as Buy at Deutsche Bank.
Amylin Pharmaceuticals (NASDAQ: AMLN) Started as Buy at Jefferies.
Bank of America Corporation (NYSE: BAC) Started as Buy at UBS.
Biovail Corp. (NYSE: BVF) Started as Overweight at Thomas Weisel.
Crown Castle International Corp. (NYSE: CCI) Started as Buy at Deutsche Bank.
Electronic Arts Inc. (NASDAQ: ERTS) Raised to Buy at Needham.
Forest Laboratories (NYSE: FRX) Started as Outperform at Oppenheimer.
Intel Corp. (NASDAQ: INTC) Reiterated Sell at Auriga.
Qwest Communications (NYSE: Q) Started as Buy at Deutsche Bank.
Verizon Communications (NYSE: VZ) Started as Buy at Deutsche Bank.
You can sign up for our free daily email to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG